Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Aug. 14, 2024
With
the
COVID-19
pandemic,
importance
of
vaccines
has
been
widely
recognized
and
led
to
increased
research
development
efforts.
Vaccines
also
play
a
crucial
role
in
cancer
treatment
by
activating
immune
system
target
destroy
cells.
However,
enhancing
efficacy
remains
challenge.
Adjuvants,
which
enhance
response
antigens
improve
vaccine
effectiveness,
have
faced
limitations
recent
years,
resulting
few
novel
adjuvants
being
identified.
The
advancement
artificial
intelligence
(AI)
technology
drug
provided
foundation
for
adjuvant
screening
application,
leading
diversification
adjuvants.
This
article
reviews
significant
tumor
basic
clinical
explores
use
AI
screen
from
databases.
findings
this
review
offer
valuable
insights
new
next-generation
vaccines.
Language: Английский
Bispecific antibodies and CLEM: an analytical approach to advanced cell imaging for therapeutic strategies
Han‐ul Kim,
No information about this author
Young Kwan Kim
No information about this author
Han-guk hyeonmigyeong hakoeji/Applied microscopy,
Journal Year:
2025,
Volume and Issue:
55(1)
Published: Jan. 20, 2025
Abstract
The
development
of
bispecific
antibodies
(BsAbs)
represents
a
significant
advancement
in
therapeutic
antibody
design,
enabling
the
simultaneous
targeting
two
different
antigens.
This
dual-targeting
capability
enhances
efficacy,
particularly
complex
diseases
like
cancer,
where
tumor
heterogeneity
presents
challenge
for
traditional
treatments.
By
bridging
distinct
pathways,
BsAbs
can
improve
specificity
and
minimize
off-target
effects,
making
them
invaluable
contexts.
Integrating
advanced
imaging
techniques,
Correlative
Light
Electron
Microscopy
(CLEM),
offers
unique
opportunity
to
visualize
dynamic
interactions
within
cellular
environments.
CLEM
combines
strengths
optical
electron
microscopy,
allowing
researchers
observe
real-time
antibody-antigen
at
nanoscale
resolution.
synergy
not
only
deepens
our
understanding
BsAbs’
mechanisms
action
but
also
provides
critical
insights
into
their
spatial
distribution,
binding
kinetics,
functional
dynamics
live
cells.
In
this
review,
integration
paves
way
targeted
strategies,
fostering
more
effective
treatments
that
adapt
complexities
disease
pathology.
Language: Английский
BUB1 Inhibition Induces Ferroptosis in Triple-Negative Breast Cancer Cell Lines
Sushmitha Sriramulu,
No information about this author
Shivani Thoidingjam,
No information about this author
Stephen L. Brown
No information about this author
et al.
DNA,
Journal Year:
2025,
Volume and Issue:
5(1), P. 16 - 16
Published: March 12, 2025
Background:
Triple-negative
breast
cancer
(TNBC)
is
a
highly
aggressive
subtype
with
limited
effective
treatments
available,
including
targeted
therapies,
often
leading
to
poor
prognosis.
Mitotic
checkpoint
kinase
BUB1
frequently
overexpressed
in
TNBC
and
correlates
survival
outcomes
suggesting
its
potential
as
therapeutic
target.
This
study
explores
the
cytotoxicity
of
cells
inhibition,
alone
or
combination
radiation
demonstrates
that
ferroptosis,
an
iron-dependent
form
programmed
cell
death,
has
role.
Methods:
lines
(SUM159,
MDA-MB-231,
BT-549)
were
treated
inhibitor
BAY1816032
(BUB1i)
ferroptosis
activator
RSL3
without
4
Gy
irradiation.
Cell
viability
assays
conducted
assess
treatment
effects,
qPCR
analyses
measured
expression
key
markers
ACSL4,
GPX4,
PTGS2,
SLC7A11,
NCOA4,
IREB2,
NFS1,
TFRC
expression,
TBARS
assay
lipid
peroxidation
levels.
Ferroptosis
specificity
was
confirmed
through
co-treatment
Ferrostatin-1
(F-1).
Results:
In
all
studied,
inhibition
significantly
induced
marked
by
increased
ACSL4
decreased
GPX4
The
BUB1i
further
amplified
these
ferroptotic
markers,
at
least
additive
effect,
which
not
present
radiation.
Co-treatment
reversed
BUB1i-mediated
death
may
involve
signaling
lines.
Conclusions:
independently
induce
lines,
enhanced
when
combined
activator.
Further
research
warranted
delineate
molecular
mechanism
BUB1-mediated
TNBC.
Language: Английский
Lipid nanoparticles-based RNA therapies for breast cancer treatment
Luigia Serpico,
No information about this author
Yuewen Zhu,
No information about this author
Renata Faria Maia
No information about this author
et al.
Drug Delivery and Translational Research,
Journal Year:
2024,
Volume and Issue:
14(10), P. 2823 - 2844
Published: June 3, 2024
Abstract
Breast
cancer
(BC)
prevails
as
a
major
burden
on
global
healthcare,
being
the
most
prevalent
form
of
among
women.
BC
is
complex
and
heterogeneous
disease,
current
therapies,
such
chemotherapy
radiotherapy,
frequently
fall
short
in
providing
effective
solutions.
These
treatments
fail
to
mitigate
risk
recurrence
cause
severe
side
effects
that,
turn,
compromise
therapeutic
responses
patients.
Over
last
decade,
several
strategies
have
been
proposed
overcome
these
limitations.
Among
them,
RNA-based
technologies
demonstrated
their
potential
across
various
clinical
applications,
notably
therapy.
However,
RNA
therapies
are
still
limited
by
series
critical
issues
like
off-target
effect
poor
stability
circulation.
Thus,
novel
approaches
investigated
improve
targeting
bioavailability
formulations
achieve
an
appropriate
outcome.
Lipid
nanoparticles
(LNPs)
largely
proven
be
advantageous
carrier
for
nucleic
acids
RNA.
This
perspective
explores
recent
advances
technology
with
emphasis
LNPs’
utilization
nanocarriers
therapy
progresses
applications.
Graphical
Language: Английский
Polyphenols as Immunomodulators and Epigenetic Modulators: An Analysis of Their Role in the Treatment and Prevention of Breast Cancer
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(23), P. 4143 - 4143
Published: Nov. 29, 2024
Breast
cancer
poses
a
substantial
health
challenge
for
women
globally.
Recently,
there
has
been
notable
increase
in
scholarly
attention
regarding
polyphenols,
primarily
attributed
to
not
only
the
adverse
effects
associated
with
conventional
treatments
but
also
their
immune-preventive
impacts.
Polyphenols,
nature-derived
substances
present
vegetation,
including
fruits
and
vegetables,
have
received
considerable
various
fields
of
science
due
probable
wellness
merits,
particularly
treatment
hindrance
cancer.
This
review
focuses
on
immunomodulatory
polyphenols
breast
cancer,
emphasizing
capacity
influence
reaction
adaptive
innate
immune
cells
within
tumor-associated
environment.
Polyphenols
are
implicated
modulation
inflammation,
enhancement
antioxidant
defenses,
promotion
epigenetic
modifications,
support
functions.
Additionally,
these
compounds
shown
activity
critical
cells,
macrophages
T
cells.
By
targeting
pathways
involved
evasion,
may
augment
defensive
system
detect
eliminate
tumors.
The
findings
suggest
that
incorporating
polyphenol-rich
foods
into
diet
could
offer
promising,
collaborative
(integrative)
approach
classical
remedial
procedures
by
regulating
how
defense
mechanism
interacts
disease.
Language: Английский